Applying for grants
GrantConnect – the Australian Government’s grants hub – lists current MRFF grants. Researchers can register with GrantConnect and sign up for alerts about MRFF grants.
You can also search GrantConnect for previous grants awarded under the MRFF. A list of grant recipients is also available.
Current MRFF initiatives
The following initiatives are part of the MRFF 10-year Investment Plan.
-
Australian Brain Cancer Mission
The Australian Brain Cancer Mission is investing $126.4 million to support research into brain cancer. It aims to double the survival rates and improve the quality of life of patients with brain cancer. -
Cardiovascular Health Mission
The Cardiovascular Health Mission is investing $220 million. It brings together researchers, health professionals, industry and patients to make transformative improvements in heart and vascular health and stroke for all Australians. -
Clinical Trials Activity initiative
The Clinical Trials Activity initiative will provide $750 million over 10 years from 2024–25. It will help Australian researchers and patients test new treatments through national and international clinical trials. It will also support research on rare cancers, rare diseases and unmet needs. -
Clinician Researchers initiative
The Clinician Researchers initiative will provide $200 million over 10 years from 2024–25 to support the next generation of talented Australian researchers. It will support health care professionals researching topics important to clinical care. -
Dementia, Ageing and Aged Care Mission
The Dementia, Ageing and Aged Care Mission is investing $185 million. It supports older Australians to maintain their health and quality of life as they age, live independently for longer, and access quality care when they need it. -
Early to Mid-Career Researchers initiative
The Early to Mid-Career Researchers initiative will invest $433.6 million over 10 years from 2024–25 in early to mid-career researchers (EMCRs). The initiative will build and grow research capacity and capability in Australia by supporting EMCRs to continue their health and medical research careers. -
Emerging Priorities and Consumer-Driven Research initiative
The Emerging Priorities and Consumer-Driven Research initiative will provide $653.6 million over 10 years from 2024–25. It will support high-quality research that improves patient care, translates new discoveries into practice, and encourages consumers and researchers to work together. -
Frontier Health and Medical Research initiative
The Frontier Health and Medical Research initiative will provide $700 million over 10 years from 2024–25 to support researchers to develop new health and medical breakthroughs. -
Genomics Health Futures Mission
The Genomics Health Futures Mission is investing $500.1 million in genomic research. It will improve testing and diagnosis for many diseases, help personalise treatment options to better target and improve health outcomes. It will also reduce unnecessary interventions and health costs. -
Global Health initiative
The Global Health initiative will provide $30 million over 10 years from 2024–25 to fund projects that improve our understanding of global health threats and how best to tackle them. -
Indigenous Health Research Fund
The Indigenous Health Research Fund is investing $160 million in Indigenous-led research to tackle health issues facing Aboriginal and Torres Strait Islander people. -
Medical Research Commercialisation initiative
The Medical Research Commercialisation initiative will provide $450 million over 10 years from 2024–25 to support innovative early stage health and medical research in Australia. It will help researchers transform ideas into life-saving medicines, devices and treatments to help future patients. -
Million Minds Mental Health Research Mission
The Million Minds Mental Health Research Mission is investing $125 million to support a million Australians with mental health issues. This funding will enable access to new approaches to prevention, diagnosis, treatment and recovery. -
National Critical Research Infrastructure initiative
This initiative will provide $600 million over 10 years from 2024–25 for research infrastructure that will be used to conduct world-class health and medical research. -
Preventive and Public Health Research initiative
The Preventive and Public Health Research initiative will provide $545.1 million over 10 years from 2024–25. It will fund targeted research into new ways to address risk factors for chronic and complex diseases in Australia. -
Primary Health Care Research initiative
The Primary Health Care Research initiative will provide $100 million over 10 years from 2024–25. It aims to support an increase in Australia’s evidence base in primary health care through research to improve service delivery and patient outcomes, and translate this knowledge into action. -
Rapid Applied Research Translation initiative
The Rapid Applied Research Translation initiative will provide $230 million over 10 years from 2024–25 to support the translation of evidence (through research) into clinical practice. -
Research Data Infrastructure initiative
The Research Data Infrastructure initiative will provide $100 million over 10 years from 2024–25. It will fund the creation or extension of national research data infrastructure with a focus on data registries, biobanks and data linkage platforms to support Australian medical research. -
Stem Cell Therapies Mission
The Stem Cell Therapies Mission is investing $150 million to develop innovative, safe and effective treatments to improve health outcomes, in partnership with patients and carers. -
Traumatic Brain Injury Mission
The Traumatic Brain Injury Mission is investing $50 million to improve patient recovery after brain injury. It will support projects that predict recovery outcomes, or identify the most effective care and treatments.
Previous MRFF initiatives
These initiatives have either been consolidated under a current initiative above or have finished.
-
Accelerated Research initiative
Accelerated Research has been consolidated into the Emerging Priorities and Consumer-Driven Research initiative under the MRFF 10-year Investment Plan. This initiative supported researchers working to develop new treatments and cures for debilitating conditions, in areas of identified unmet need. -
Biomedical Translation Bridge initiative
The Biomedical Translation Bridge (BTB) is now part of the Medical Research Commercialisation initiative under the MRFF 10-year Investment Plan. -
BioMedTech Horizons initiative
BioMedTech Horizons is now part of the Medical Research Commercialisation initiative under the MRFF 10-year Investment Plan. -
Boosting Preventive Health Research initiative
This initiative invested $10 million in research to help promote good health practice, prevent disease and keep people out of hospital. -
International Clinical Trial Collaboration (ICTC) initiative
The International Clinical Trial Collaboration (ICTC) initiative has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan. ICTC supported Australian researchers to conduct clinical trial research in collaboration with international researchers. -
Keeping Australians out of Hospital initiative
Keeping Australians out of Hospital has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan. This initiative supported research into preventive health measures for chronic health conditions, to keep people out of hospital. -
Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative
Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative has been consolidated into a part of the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan. -
Maternal Health and First 2000 Days/Women’s Health initiative
Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan. -
National Security Against Pandemic Risk initiative
The National Security Against Pandemic Risk initiative contributed to a global effort to develop vaccines against future pandemic diseases. -
Rare Cancers, Rare Diseases and Unmet Need Clinical Trials initiative
Rare Cancers, Rare Diseases and Unmet Need Clinical Trials has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year Investment Plan. -
Researcher Exchange and Development within Industry initiative
The Researcher Exchange and Development within Industry initiative was an initiative under the Medical Research Future. It funded industry placements, mentoring and exchange programs for researchers. -
Tackling Antimicrobial Resistance in Aged Care Facilities initiative
Tackling Antimicrobial Resistance in Aged Care Facilities has been consolidated into the Global Health initiative under the MRFF 10-year Investment Plan. This initiative helped tackle the threat of microbes such as bacteria, viruses or parasites becoming resistant to standard medical treatments. -
Targeted Health System and Community Organisation Research initiative
Targeted Health System and Community Organisation Research has been consolidated into Preventive and Public Health Research under the MRFF 10-year Investment Plan. The activity provides a way to compare the effectiveness of health services and address areas of health care practice with low evidence. -
Targeted Translation Research Accelerator initiative
Targeted Translation Research Accelerator has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year Investment Plan.
Date last updated: